Tirofiban

Also known as: Tirofiban hydrochloride

Active ingredient description

Tirofiban is a non-peptidal antagonist of the GP IIb/IIIa receptor, an important platelet surface receptor involved in platelet aggregation. Tirofiban prevents fibrinogen from binding to the GP IIb/IIIa receptor, thus blocking platelet aggregation.

Medicine classification

This medicinal substance has been classified in the anatomical therapeutic chemical (ATC) classification according to its main therapeutic use as follows:

ATC code
Group title
Classification
Tirofiban
B Blood and blood forming organs → B01 Antithrombotic agents → B01A Antithrombotic agents → B01AC Platelet aggregation inhibitors excl. heparin
Discover more medicines within B01AC17

Medicines

Tirofiban is the active ingredient of these drugs:

Drug
Countries

Cyprus

Australia Austria Canada Cyprus Finland

Brazil France Spain

Lithuania

Product monographs

Medicine agencies around the world have authorized marketing of this active ingredient according to these medication package inserts (MPIs):

Title
Type
Country
Summary of Product Characteristics (SPC)
UK

Structural formula

Graphic representation of the active ingredient's molecular structure

Unique ingredient identifier (UNII)

6H925F8O5J - TIROFIBAN HYDROCHLORIDE

GGX234SI5H - TIROFIBAN

CAS registry number

144494-65-5 - tirofiban

SNOMED-CT

386953003 - Tirofiban (substance)